Navigation Links
Leptin action in the brain linked to sepsis survival
Date:4/30/2010

CINCINNATIThe hormone leptin, typically associated with body weight regulation, works within the central nervous system (CNS) to aid the immune system's defense against sepsis, researchers say.

Sepsis is a life-threatening medical condition in which the entire body is overwhelmed by infection.

A study led by Matthias Tschp, MD, of UC's Metabolic Diseases Institute, and Charles Caldwell, PhD, of UC's surgery department, is the first to describe leptin's role in the control of immune response via the CNS. Results are published this week in the Journal of Neuroscience, the official journal of the Society for Neuroscience.

"Indirect evidence has previously indicated that the central nervous system might have a role in maintaining the immune system," says Tschp. "For example, people with brain injuries appear to be at a higher risk for infection and sepsis. Sepsis is also a serious complication for stroke patients. What was lacking was any molecular mechanism to explain that relationship."

Researchers know that obesity causes an overproduction of leptin. High leptin levels make receptors "deaf" to the hormone, resulting in a loss of leptin function (leptin resistance) that leads to higher food intake.

Diet-induced induced obese mice have a survival advantage in sepsis. Because of this, the team hypothesized that leptin resistance, which is seen at neurons regulating body weight, may not be happening at the brain centers that regulate the immune system.

To prove this, the team studied several leptin-deficient mouse models, including one that was missing leptin receptors everywhere except within the CNS. They report that leptin, long thought to act directly on immune cells themselves, also mediates actions in the CNS. They showed that leptin replacement improved the host response to a standard model of sepsis.

Leptin-dependent neurocircuitry, the authors say, is required for a proper immune response to sepsis, and damage to this circuitry, or even leptin deficiency, may lead to higher risk of death from sepsis.

"Human congenital leptin deficiency is rare," the authors say, "with less than a few dozen patients reported worldwide to date. But there is a stunning number of recorded cases of death due to sepsis in this patient population."

In addition, Tschp says, this new finding gives researchers clues that could help in developing therapeutic targets for treating infection in people with damaged leptin-dependent neurocircuitry.


'/>"/>

Contact: Dama Kimmon
dama.kimmon@uc.edu
513-558-4519
University of Cincinnati Academic Health Center
Source:Eurekalert

Related biology news :

1. Joslin researchers uncover potential role of leptin in diabetes
2. Leptins long-distance call to the pancreas
3. Facial attraction -- choice of sexual partner shaped the human face
4. Interaction of just 2 genes governs coloration patterns in mice
5. Hidden interactions between predators and prey: evolution causes cryptic dynamics in ecology
6. Voice Biometrics Gains Traction as Most Accurate and Convenient Technology to Secure Customer Privacy
7. Skin oil -- ozone interactions worsen air quality in airplanes
8. Gray whales a fraction of historic levels, genetic research says
9. Keck Foundation funds study of biological interactions with nanomaterials
10. Neuronal conduction of excitation without action potentials based on ceramide production
11. Majority of Americans want local action on global warming, says poll
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... CHICAGO , March 29, 2017  higi, the ... ecosystem in North America , today ... Partners and the acquisition of EveryMove. The new investment ... extensive set of tools to transform population health activities ... and lifestyle data. higi collects and secures ...
Breaking Biology News(10 mins):
(Date:7/20/2017)... ... ... VIC Technology Venture Development™ (VIC™), is pleased to announce that James ... to strengthen and diversify VIC’s board. , "We are excited to have Jamie join ... business executive with a broad range of experience directly relevant to VIC as we ...
(Date:7/20/2017)... ... 2017 , ... Crucial Data Solutions (CDS) is excited to ... unified. TrialKit, a native mobile app, empowers investigators and clinicians to build, deploy, ... mobile devices. With TrialKit, clinical researchers can utilize Core Motion technologies and Apple’s ...
(Date:7/18/2017)... ... July 18, 2017 , ... G-CON today announced that ... Office for its Patent Applications 14/858,857 and 13/669,785 both entitled Modular, Self-Contained, Mobile ... further expand the protection of G-CON’s R&D investments and validate the G-CON platform ...
(Date:7/17/2017)... ... July 17, 2017 , ... Whitehouse Laboratories is excited ... encompass the full series of ISO 80369 standard test procedures. The ISO 80369 ... and drug delivery systems. With this recent expansion, Whitehouse Labs becomes one of ...
Breaking Biology Technology: